{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:07:01Z","timestamp":1789967221497,"version":"4.0.1"},"reference-count":170,"publisher":"Walter de Gruyter GmbH","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Colorectal cancer remains an important cause of mortality worldwide. The presence of peritoneal carcinomatosis (PC) causes significant symptoms and is notoriously difficult to treat. Therefore, informative preclinical research into the mechanisms and possible novel treatment options of colorectal PC is essential in order to improve the prognostic outlook in these patients. Several syngeneic and xenograft animal models of colorectal PC were established, studying a wide range of experimental procedures and substances. Regrettably, more sophisticated models such as those giving rise to spontaneous PC or involving genetically engineered mice are lacking. Here, we provide an overview of all reported colorectal PC animal models and briefly discuss their use, strengths, and limitations.<\/jats:p>","DOI":"10.1515\/pp-2016-0006","type":"journal-article","created":{"date-parts":[[2016,4,13]],"date-time":"2016-04-13T15:15:08Z","timestamp":1460560508000},"page":"23-43","source":"Crossref","is-referenced-by-count":25,"title":["Animal models of colorectal peritoneal metastasis"],"prefix":"10.1515","volume":"1","author":[{"given":"F\u00e9lix","family":"Gremonprez","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Surgery, Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Willaert","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Ceelen","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Ghent University Hospital, 2K12 IC UZ Gent De Pintelaan 185, 9000 Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2016,4,12]]},"reference":[{"key":"2025120909190353520_j_pp-2016-0006_ref_001_w2aab3b7c23b1b6b1ab2b1b1Aa","unstructured":"1. Herszenyi L, Tulassay Z. Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci 2010;14(4):249\u201358."},{"key":"2025120909190353520_j_pp-2016-0006_ref_002_w2aab3b7c23b1b6b1ab2b1b2Aa","doi-asserted-by":"crossref","unstructured":"2. Royston D, Jackson DG. Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma. J Pathol 2009;217(5):608\u201319.","DOI":"10.1002\/path.2517"},{"key":"2025120909190353520_j_pp-2016-0006_ref_003_w2aab3b7c23b1b6b1ab2b1b3Aa","doi-asserted-by":"crossref","unstructured":"3. Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, et\u2009al. Colorectal cancer. Lancet 2010;375(9719):1030\u201347.","DOI":"10.1016\/S0140-6736(10)60353-4"},{"key":"2025120909190353520_j_pp-2016-0006_ref_004_w2aab3b7c23b1b6b1ab2b1b4Aa","doi-asserted-by":"crossref","unstructured":"4. Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I, Lippert H. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum 2010;53(1):57\u201364.","DOI":"10.1007\/DCR.0b013e3181c703a4"},{"key":"2025120909190353520_j_pp-2016-0006_ref_005_w2aab3b7c23b1b6b1ab2b1b5Aa","unstructured":"5. Knorr C, Reingruber B, Meyer T, Hohenberger W, Stremmel C. Peritoneal carcinomatosis of colorectal cancer: incidence, prognosis, and treatment modalities. Int. J. Colorectal Dis 2004;19(3):181\u20137."},{"key":"2025120909190353520_j_pp-2016-0006_ref_006_w2aab3b7c23b1b6b1ab2b1b6Aa","doi-asserted-by":"crossref","unstructured":"6. Koppe MJ, Boerman OC, Oyen WJG, Bleichrodt RP. Peritoneal carcinomatosis of colorectal origin \u2013 incidence and current treatment strategies. Ann Surg 2006;243(2):212\u201322.","DOI":"10.1097\/01.sla.0000197702.46394.16"},{"key":"2025120909190353520_j_pp-2016-0006_ref_007_w2aab3b7c23b1b6b1ab2b1b7Aa","doi-asserted-by":"crossref","unstructured":"7. Ceelen WP, Flessner MF. Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence. Nat Rev Clin Oncol 2010;7(2):108\u201315.","DOI":"10.1038\/nrclinonc.2009.217"},{"key":"2025120909190353520_j_pp-2016-0006_ref_008_w2aab3b7c23b1b6b1ab2b1b8Aa","unstructured":"8. Warrick C. An improvement on the Practice of tapping; whereby that operation, instead of a relief for symptoms, becomes an absolute cure for an ascites, exemplified in the case of Jane Roman; and recommended to the consideration of the royal society, by Christopher Warrick, of Truro, surgeon. Phil Tran 1753;43(472\u2013477):12\u201319."},{"key":"2025120909190353520_j_pp-2016-0006_ref_009_w2aab3b7c23b1b6b1ab2b1b9Aa","doi-asserted-by":"crossref","unstructured":"9. Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, et\u2009al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006;354(1):34\u201343.","DOI":"10.1056\/NEJMoa052985"},{"key":"2025120909190353520_j_pp-2016-0006_ref_010_w2aab3b7c23b1b6b1ab2b1c10Aa","doi-asserted-by":"crossref","unstructured":"10. Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, et\u2009al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 2012;30(20):2449\u201356.","DOI":"10.1200\/JCO.2011.39.7166"},{"key":"2025120909190353520_j_pp-2016-0006_ref_011_w2aab3b7c23b1b6b1ab2b1c11Aa","unstructured":"11. Corbett TH, Griswold Jr DP, Roberts BJ, Peckham JC, Schabel Jr FM. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res 1975;35(9):2434\u20139."},{"key":"2025120909190353520_j_pp-2016-0006_ref_012_w2aab3b7c23b1b6b1ab2b1c12Aa","doi-asserted-by":"crossref","unstructured":"12. Castle JC, Loewer M, Boegel S, de Graaf J, Bender C, Tadmor AD, et\u2009al. Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma. BMC Genomics 2014;15:190.","DOI":"10.1186\/1471-2164-15-190"},{"key":"2025120909190353520_j_pp-2016-0006_ref_013_w2aab3b7c23b1b6b1ab2b1c13Aa","doi-asserted-by":"crossref","unstructured":"13. Marquet RL, Westbroek DL, Jeekel J. Interferon treatment of a transplantable rat colon adenocarcinoma: importance of tumor site. Int J Cancer 1984;33(5):689\u201392.","DOI":"10.1002\/ijc.2910330521"},{"key":"2025120909190353520_j_pp-2016-0006_ref_014_w2aab3b7c23b1b6b1ab2b1c14Aa","doi-asserted-by":"crossref","unstructured":"14. Cardozo A, Gupta A, Koppe MJ, Meijer S, van Leeuwen PAM, Beelen RJH, et\u2009al. Metastatic pattern of CC531 colon carcinoma cells in the abdominal cavity: an experimental model of peritoneal carcinomatosis in rats. Eur J Surg Oncol 2001;27(4):359\u201363.","DOI":"10.1053\/ejso.2001.1117"},{"key":"2025120909190353520_j_pp-2016-0006_ref_015_w2aab3b7c23b1b6b1ab2b1c15Aa","doi-asserted-by":"crossref","unstructured":"15. Inoue Y, Kashima Y, Aizawa K, Hatakeyama K. A new rat colon cancer cell line metastasizes spontaneously: biologic characteristics and chemotherapeutic response. Jpn J Cancer Res 1991;82(1):90\u20137.","DOI":"10.1111\/j.1349-7006.1991.tb01751.x"},{"key":"2025120909190353520_j_pp-2016-0006_ref_016_w2aab3b7c23b1b6b1ab2b1c16Aa","doi-asserted-by":"crossref","unstructured":"16. Sausville EA, Burger AM. Contributions of human tumor xenografts to anticancer drug development. Cancer Res 2006;66(7):3351\u20134; discussion 3354.","DOI":"10.1158\/0008-5472.CAN-05-3627"},{"key":"2025120909190353520_j_pp-2016-0006_ref_017_w2aab3b7c23b1b6b1ab2b1c17Aa","doi-asserted-by":"crossref","unstructured":"17. Khaled WT, Liu P. Cancer mouse models: past, present and future. Semin Cell Dev Biol 2014;27:54\u201360.","DOI":"10.1016\/j.semcdb.2014.04.003"},{"key":"2025120909190353520_j_pp-2016-0006_ref_018_w2aab3b7c23b1b6b1ab2b1c18Aa","doi-asserted-by":"crossref","unstructured":"18. Kotanagi H, Saito Y, Yoshioka T, Koyama K. Characteristics of two cancer cell lines derived from metastatic foci in liver and peritoneum of a patient with colon cancer. Journal of Gastroenterology 1998;33(6):842\u20139.","DOI":"10.1007\/s005350050185"},{"key":"2025120909190353520_j_pp-2016-0006_ref_019_w2aab3b7c23b1b6b1ab2b1c19Aa","doi-asserted-by":"crossref","unstructured":"19. Flatmark K, Davidson B, Kristian A, Stavnes HT, Forsund M, Reed W. Exploring the peritoneal surface malignancy phenotype-a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models. Hum Pathol 2010;41(8):1109\u201319.","DOI":"10.1016\/j.humpath.2009.12.013"},{"key":"2025120909190353520_j_pp-2016-0006_ref_020_w2aab3b7c23b1b6b1ab2b1c20Aa","unstructured":"20. Navarro-Alvarez N, Kondo E, Kawamoto H, Hassan W, Yuasa T, Kubota Y, et\u2009al. Propagation of a human CD133(-) colon tumor-derived cell line with tumorigenic and angiogenic properties. Cell Trans 2010;19(6\u20137):865\u201377."},{"key":"2025120909190353520_j_pp-2016-0006_ref_021_w2aab3b7c23b1b6b1ab2b1c21Aa","doi-asserted-by":"crossref","unstructured":"21. Abdul-Wahid A, Huang EHB, Lu H, Flanagan J, Mallick AI, Gariepy J. A focused immune response targeting the homotypic binding domain of the carcinoembryonic antigen blocks the establishment of tumor foci in vivo. Int J Cancer 2012;131(12):2839\u201351.","DOI":"10.1002\/ijc.27582"},{"key":"2025120909190353520_j_pp-2016-0006_ref_022_w2aab3b7c23b1b6b1ab2b1c22Aa","doi-asserted-by":"crossref","unstructured":"22. Meredith AL. Viral skin diseases of the rabbit. Vet Clin North Am Exot Anim Pract 2013;16(3):705\u201314.","DOI":"10.1016\/j.cvex.2013.05.010"},{"key":"2025120909190353520_j_pp-2016-0006_ref_023_w2aab3b7c23b1b6b1ab2b1c23Aa","doi-asserted-by":"crossref","unstructured":"23. Tang L, Duan R, Zhong YJ, Firestone RA, Hong YP, Li JG, et\u2009al. Synthesis, identification and in vivo studies of tumor-targeting agent peptide doxorubicin (PDOX) to treat peritoneal carcinomatosis of gastric cancer with similar efficacy but reduced toxicity. Mol Cancer 2014;13(1):13\u201344.","DOI":"10.1186\/1476-4598-13-44"},{"key":"2025120909190353520_j_pp-2016-0006_ref_024_w2aab3b7c23b1b6b1ab2b1c24Aa","doi-asserted-by":"crossref","unstructured":"24. Tang L, Mei L-J, Yang X-J, Huang C-Q, Zhou Y-F, Yonemura Y, et\u2009al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study. J Trans Med 2011;9:53.","DOI":"10.1186\/1479-5876-9-53"},{"key":"2025120909190353520_j_pp-2016-0006_ref_025_w2aab3b7c23b1b6b1ab2b1c25Aa","doi-asserted-by":"crossref","unstructured":"25. Turner JH, Rose AH, Glancy RJ, Penhale WJ. Orthotopic xenografts of human melanoma and colonic and ovarian carcinoma in sheep to evaluate radioimmunotherapy. Br J Cancer 1998;78(4):486\u201394.","DOI":"10.1038\/bjc.1998.520"},{"key":"2025120909190353520_j_pp-2016-0006_ref_026_w2aab3b7c23b1b6b1ab2b1c26Aa","doi-asserted-by":"crossref","unstructured":"26. Hewett PJ, Thomas WM, King G, Eaton M. Intraperitoneal cell movement during abdominal carbon dioxide insufflation and laparoscopy \u2013 an in vivo model. Dis Colon Rectum 1996;39(10):S62\u2013S66.","DOI":"10.1007\/BF02053808"},{"key":"2025120909190353520_j_pp-2016-0006_ref_027_w2aab3b7c23b1b6b1ab2b1c27Aa","doi-asserted-by":"crossref","unstructured":"27. Cespedes MV, Espina C, Garcia-Cabezas MA, Trias M, Boluda A, Gomez del Pulgar MT, et\u2009al. Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sites. Am J Pathol 2007;170(3):1077\u201385.","DOI":"10.2353\/ajpath.2007.060773"},{"key":"2025120909190353520_j_pp-2016-0006_ref_028_w2aab3b7c23b1b6b1ab2b1c28Aa","doi-asserted-by":"crossref","unstructured":"28. Cespedes MV, Larriba MJ, Pavon MA, Alamo P, Casanova I, Parreno M, et\u2009al. Site-dependent E-cadherin cleavage and nuclear translocation in a metastatic colorectal cancer model. Am J Pathol 2010;177(4):2067\u201379.","DOI":"10.2353\/ajpath.2010.100079"},{"key":"2025120909190353520_j_pp-2016-0006_ref_029_w2aab3b7c23b1b6b1ab2b1c29Aa","doi-asserted-by":"crossref","unstructured":"29. Puig I, Chicote I, Tenbaum SP, Arques O, Herance JR, Gispert JD, et\u2009al. A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cells. Clin Cancer Res 2013;19(24):6787\u2013801.","DOI":"10.1158\/1078-0432.CCR-12-1740"},{"key":"2025120909190353520_j_pp-2016-0006_ref_030_w2aab3b7c23b1b6b1ab2b1c30Aa","doi-asserted-by":"crossref","unstructured":"30. Gremonprez F, Descamps B, Izmer A, Vanhove C, Vanhaecke F, De Wever O, et\u2009al. Pretreatment with VEGF(R)-inhibitors reduces interstitial fluid pressure, increases intraperitoneal chemotherapy drug penetration, and impedes tumor growth in a mouse colorectal carcinomatosis model. Oncotarget 2015;6(30):29889\u2013900.","DOI":"10.18632\/oncotarget.5092"},{"key":"2025120909190353520_j_pp-2016-0006_ref_031_w2aab3b7c23b1b6b1ab2b1c31Aa","doi-asserted-by":"crossref","unstructured":"31. Chen C, Peng J, Sun SR, Peng CW, Li Y, Pang DW. Tapping the potential of quantum dots for personalized oncology: current status and future perspectives. Nanomedicine (Lond 2012;7(3):411\u201328.","DOI":"10.2217\/nnm.12.9"},{"key":"2025120909190353520_j_pp-2016-0006_ref_032_w2aab3b7c23b1b6b1ab2b1c32Aa","doi-asserted-by":"crossref","unstructured":"32. Mikula-Pietrasik J, Sosinska P, Maksin K, Kucinska M, Piotrowska H, Murias M, et\u2009al. Colorectal cancer-promoting activity of the senescent peritoneal mesothelium. Oncotarget 2015;6(30):29178\u201395.","DOI":"10.18632\/oncotarget.4932"},{"key":"2025120909190353520_j_pp-2016-0006_ref_033_w2aab3b7c23b1b6b1ab2b1c33Aa","doi-asserted-by":"crossref","unstructured":"33. Inoue T, Tashiro Y, Takeuchi M, Otani T, Tsuji-Takayama K, Okochi A, et\u2009al. Potent anti-tumor killing activity of the multifunctional Treg cell line HOZOT against human tumors with diverse origins. Int J Oncol 2011;38(5):1299\u2013306.","DOI":"10.3892\/ijo.2011.962"},{"key":"2025120909190353520_j_pp-2016-0006_ref_034_w2aab3b7c23b1b6b1ab2b1c34Aa","doi-asserted-by":"crossref","unstructured":"34. Lubbe WJ, Zuzga DS, Zhou Z, Fu W, Pelta-Heller J, Muschel RJ, et\u2009al. Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9. Cancer Res 2009;69(8):3529\u201336.","DOI":"10.1158\/0008-5472.CAN-09-0067"},{"key":"2025120909190353520_j_pp-2016-0006_ref_035_w2aab3b7c23b1b6b1ab2b1c35Aa","doi-asserted-by":"crossref","unstructured":"35. Harada N, Mizoi T, Kinouchi M, Hoshi K, Ishii S, Shiiba K, et\u2009al. Introduction of antisense CD44S cDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells. Int J Cancer 2001;91(1):67\u201375.","DOI":"10.1002\/1097-0215(20010101)91:1<67::AID-IJC1011>3.0.CO;2-D"},{"key":"2025120909190353520_j_pp-2016-0006_ref_036_w2aab3b7c23b1b6b1ab2b1c36Aa","doi-asserted-by":"crossref","unstructured":"36. Sakamoto M, Takamura M, Ino Y, Miura A, Genda T, Hirohashi S. Involvement of c-Src in carcinoma cell motility and metastasis. Jpn J Cancer Res 2001;92(9):941\u20136.","DOI":"10.1111\/j.1349-7006.2001.tb01184.x"},{"key":"2025120909190353520_j_pp-2016-0006_ref_037_w2aab3b7c23b1b6b1ab2b1c37Aa","doi-asserted-by":"crossref","unstructured":"37. Watson SA, Morris TM, Parsons SL, Steele RJC, Brown PD. Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites model. Br J Cancer 1996;74(9):1354\u20138.","DOI":"10.1038\/bjc.1996.549"},{"key":"2025120909190353520_j_pp-2016-0006_ref_038_w2aab3b7c23b1b6b1ab2b1c38Aa","unstructured":"38. Yasui N, Sakamoto M, Ochiai A, Ino Y, Akimoto S, Orikasa A, et\u2009al. Tumor growth and metastasis of human colorectal cancer cell lines in SCID mice resemble clinical metastatic behaviors. Invasion Metastasis 1997;17(5):259\u201369."},{"key":"2025120909190353520_j_pp-2016-0006_ref_039_w2aab3b7c23b1b6b1ab2b1c39Aa","doi-asserted-by":"crossref","unstructured":"39. Wang W, Chen Y, Deng J, Zhou J, Gu X, Tang Y, et\u2009al. Cullin1 is a novel prognostic marker and regulates the cell proliferation and metastasis in colorectal cancer. J Cancer Res Clin Oncol 2015;141(9):1603\u201312.","DOI":"10.1007\/s00432-015-1931-4"},{"key":"2025120909190353520_j_pp-2016-0006_ref_040_w2aab3b7c23b1b6b1ab2b1c40Aa","doi-asserted-by":"crossref","unstructured":"40. Takemoto K, Shiozaki A, Ichikawa D, Komatsu S, Konishi H, Nako Y, et\u2009al. Evaluation of the efficacy of peritoneal lavage with distilled water in colorectal cancer surgery: in vitro and in vivo study. J Gastroenterol 2015;50(3):287\u201397.","DOI":"10.1007\/s00535-014-0971-x"},{"key":"2025120909190353520_j_pp-2016-0006_ref_041_w2aab3b7c23b1b6b1ab2b1c41Aa","doi-asserted-by":"crossref","unstructured":"41. Shen Z, Deng H, Fang Y, Zhu X, Ye G-T, Yan L, et\u2009al. Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma. Oncotarget 2015;6(24):20672\u201384.","DOI":"10.18632\/oncotarget.3967"},{"key":"2025120909190353520_j_pp-2016-0006_ref_042_w2aab3b7c23b1b6b1ab2b1c42Aa","doi-asserted-by":"crossref","unstructured":"42. Liu M, Xu A, Yuan X, Zhang Q, Fang T, Wang W, et\u2009al. Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine. J Trans Med 2015;13:195.","DOI":"10.1186\/s12967-015-0533-x"},{"key":"2025120909190353520_j_pp-2016-0006_ref_043_w2aab3b7c23b1b6b1ab2b1c43Aa","doi-asserted-by":"crossref","unstructured":"43. Lee AL, Ng VW, Gao S, Hedrick JL, Yang YY. Injectable biodegradable hydrogels from vitamin D-functionalized polycarbonates for the delivery of Avastin with enhanced therapeutic efficiency against metastatic colorectal cancer. Biomacromolecules 2015;16(2):465\u201375.","DOI":"10.1021\/bm5015206"},{"key":"2025120909190353520_j_pp-2016-0006_ref_044_w2aab3b7c23b1b6b1ab2b1c44Aa","doi-asserted-by":"crossref","unstructured":"44. Amini A, Masoumi-Moghaddam S, Ehteda A, Liauw W, Morris DL. Depletion of mucin in mucin-producing human gastrointestinal carcinoma: Results from in vitro and in vivo studies with bromelain and N-acetylcysteine. Oncotarget 2015;6(32):33329\u201344.","DOI":"10.18632\/oncotarget.5259"},{"key":"2025120909190353520_j_pp-2016-0006_ref_045_w2aab3b7c23b1b6b1ab2b1c45Aa","unstructured":"45. Tang Q, Wang Y, Huang R, You Q, Wang G, Chen Y, et\u2009al. Preparation of anti-tumor nanoparticle and its inhibition to peritoneal dissemination of colon cancer. Plos One 2014;9(6):e98455."},{"key":"2025120909190353520_j_pp-2016-0006_ref_046_w2aab3b7c23b1b6b1ab2b1c46Aa","unstructured":"46. Tanaka K, Okugawa Y, Toiyama Y, Inoue Y, Saigusa S, Kawamura M, et\u2009al. Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer. Plos One 2014;9(5):e96410."},{"key":"2025120909190353520_j_pp-2016-0006_ref_047_w2aab3b7c23b1b6b1ab2b1c47Aa","doi-asserted-by":"crossref","unstructured":"47. Rijpkema M, Oyen WJ, Bos D, Franssen GM, Goldenberg DM, Boerman OC. SPECT- and fluorescence image-guided surgery using a dual-labeled carcinoembryonic antigen-targeting antibody. J Nucl Med 2014;55(9):1519\u201324.","DOI":"10.2967\/jnumed.114.142141"},{"key":"2025120909190353520_j_pp-2016-0006_ref_048_w2aab3b7c23b1b6b1ab2b1c48Aa","doi-asserted-by":"crossref","unstructured":"48. Li X-F, Du Y, Ma Y, Postel GC, Civelek AC. F-18-fluorodeoxyglucose uptake and tumor hypoxia: revisit f-18-fluorodeoxyglucose in oncology application. Trans Oncol 2014;7(2):240\u20137.","DOI":"10.1016\/j.tranon.2014.02.010"},{"key":"2025120909190353520_j_pp-2016-0006_ref_049_w2aab3b7c23b1b6b1ab2b1c49Aa","doi-asserted-by":"crossref","unstructured":"49. Kondo Y, Murayama Y, Konishi H, Morimura R, Komatsu S, Shiozaki A, et\u2009al. Fluorescent detection of peritoneal metastasis in human colorectal cancer using 5-aminolevulinic acid. Int J Oncol 2014;45(1):41\u20136.","DOI":"10.3892\/ijo.2014.2417"},{"key":"2025120909190353520_j_pp-2016-0006_ref_050_w2aab3b7c23b1b6b1ab2b1c50Aa","doi-asserted-by":"crossref","unstructured":"50. Al-kasspooles MF, Williamson SK, Henry D, Howell J, Niu F, Decedue CJ, et\u2009al. Preclinical antitumor activity of a nanoparticulate SN38. Invest New Drugs 2013;31(4):871\u201380.","DOI":"10.1007\/s10637-012-9919-2"},{"key":"2025120909190353520_j_pp-2016-0006_ref_051_w2aab3b7c23b1b6b1ab2b1c51Aa","doi-asserted-by":"crossref","unstructured":"51. Derbal-Wolfrom L, Pencreach E, Saandi T, Aprahamian M, Martin E, Greferath R, et\u2009al. Increasing the oxygen load by treatment with myo-inositol trispyrophosphate reduces growth of colon cancer and modulates the intestine homeobox gene Cdx2. Oncogene 2013;32(36):4313\u201318.","DOI":"10.1038\/onc.2012.445"},{"key":"2025120909190353520_j_pp-2016-0006_ref_052_w2aab3b7c23b1b6b1ab2b1c52Aa","doi-asserted-by":"crossref","unstructured":"52. Shen Y, Herde R, Doxey BW, Xu C, Gray PD, Kuwada SK. Pharmacologic downregulation of c-FLIPL restores juxtacrine death receptor-mediated apoptosis in cancer cells in a peritoneal carcinomatosis model. Int J Cancer 2012;130(7):1494\u2013503.","DOI":"10.1002\/ijc.26119"},{"key":"2025120909190353520_j_pp-2016-0006_ref_053_w2aab3b7c23b1b6b1ab2b1c53Aa","doi-asserted-by":"crossref","unstructured":"53. Nayak TK, Garmestani K, Milenic DE, Brechbiel MW. PET and MRI of metastatic peritoneal and pulmonary colorectal cancer in mice with human epidermal growth factor receptor 1-targeted Zr-89-labeled panitumumab. J Nucl Med 2012;53(1):113\u201320.","DOI":"10.2967\/jnumed.111.094169"},{"key":"2025120909190353520_j_pp-2016-0006_ref_054_w2aab3b7c23b1b6b1ab2b1c54Aa","doi-asserted-by":"crossref","unstructured":"54. Ziauddin MF, Guo ZS, O\u2018Malley ME, Austin F, Popovic PJ, Kavanagh MA, et\u2009al. TRAIL gene-armed oncolytic poxvirus and oxaliplatin can work synergistically against colorectal cancer. Gene Ther 2010;17(4):550\u20139.","DOI":"10.1038\/gt.2010.5"},{"key":"2025120909190353520_j_pp-2016-0006_ref_055_w2aab3b7c23b1b6b1ab2b1c55Aa","doi-asserted-by":"crossref","unstructured":"55. Straza MW, Paliwal S, Kovi RC, Rajeshkumar B, Trenh P, Parker D, et\u2009al. Therapeutic targeting of C-terminal binding protein in human cancer. Cell Cycle 2010;9(18):3740\u201350.","DOI":"10.4161\/cc.9.18.12936"},{"key":"2025120909190353520_j_pp-2016-0006_ref_056_w2aab3b7c23b1b6b1ab2b1c56Aa","doi-asserted-by":"crossref","unstructured":"56. Li X-F, Ma Y, Sun X, Humm JL, Ling CC, O\u2018Donoghue JA. High F-18-FDG uptake in microscopic peritoneal tumors requires physiologic hypoxia. J Nucl Med 2010;51(4):632\u20138.","DOI":"10.2967\/jnumed.109.071233"},{"key":"2025120909190353520_j_pp-2016-0006_ref_057_w2aab3b7c23b1b6b1ab2b1c57Aa","doi-asserted-by":"crossref","unstructured":"57. Lan K-L, Ou-Yang F, Yen S-H, Shih H-L, Lan K-H. Cationic liposome coupled endostatin gene for treatment of peritoneal colon cancer. Clin Exp Metastasis 2010;27(5):307\u201318.","DOI":"10.1007\/s10585-010-9328-x"},{"key":"2025120909190353520_j_pp-2016-0006_ref_058_w2aab3b7c23b1b6b1ab2b1c58Aa","doi-asserted-by":"crossref","unstructured":"58. Hackl C, Lang SA, Moser C, Mori A, Fichtner-Feigl S, Hellerbrand C, et\u2009al. Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition. BMC Cancer 2010;10:668.","DOI":"10.1186\/1471-2407-10-668"},{"key":"2025120909190353520_j_pp-2016-0006_ref_059_w2aab3b7c23b1b6b1ab2b1c59Aa","doi-asserted-by":"crossref","unstructured":"59. Wagner M, Roh V, Strehlen M, Laemmle A, Stroka D, Egger B, et\u2009al. Effective treatment of advanced colorectal cancer by rapamycin and 5-FU\/oxaliplatin monitored by TIMP-1. J Gastrointest Surg 2009;13(10):1781\u201390.","DOI":"10.1007\/s11605-009-0948-x"},{"key":"2025120909190353520_j_pp-2016-0006_ref_060_w2aab3b7c23b1b6b1ab2b1c60Aa","doi-asserted-by":"crossref","unstructured":"60. Kishimoto H, Zhao M, Hayashi K, Urata Y, Tanaka N, Fujiwara T, et\u2009al. In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation. Proc Natl Acad Sci U S A 2009;106(34):14514\u201317.","DOI":"10.1073\/pnas.0906388106"},{"key":"2025120909190353520_j_pp-2016-0006_ref_061_w2aab3b7c23b1b6b1ab2b1c61Aa","doi-asserted-by":"crossref","unstructured":"61. Li X-F, Carlin S, Urano M, Russell J, Ling CC, O\u2018Donoghue JA. Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy. Cancer Res 2007;67(16):7646\u201353.","DOI":"10.1158\/0008-5472.CAN-06-4353"},{"key":"2025120909190353520_j_pp-2016-0006_ref_062_w2aab3b7c23b1b6b1ab2b1c62Aa","doi-asserted-by":"crossref","unstructured":"62. Kinuya S, Yokoyama K, Fukuoka M, Hiramatsu T, Mori H, Shiba K, et\u2009al. Intraperitoneal radioimmunotherapy to treat the early phase of peritoneal dissemination of human colon cancer cells in a murine model. Nucl Med Commun 2007;28(2):129\u201333.","DOI":"10.1097\/MNM.0b013e328013e5a8"},{"key":"2025120909190353520_j_pp-2016-0006_ref_063_w2aab3b7c23b1b6b1ab2b1c63Aa","doi-asserted-by":"crossref","unstructured":"63. Lie J-Z, Wang J-W, Qu J-G, Hung T. Suppression of human colon tumor growth by adenoviral vector-mediated NK4 expression in an athymic mouse model. World J Gastroenterol 2007;13(13):1938\u201346.","DOI":"10.3748\/wjg.v13.i13.1938"},{"key":"2025120909190353520_j_pp-2016-0006_ref_064_w2aab3b7c23b1b6b1ab2b1c64Aa","doi-asserted-by":"crossref","unstructured":"64. Sasaki T, Fujii K, Yoshida K, Shimura H, Sasahira T, Ohmori H, et\u2009al. Peritoneal metastasis inhibition by linoleic acid with activation of PPAR gamma in human gastrointestinal cancer cells. Virchows Arch 2006;448(4):422\u20137.","DOI":"10.1007\/s00428-005-0110-4"},{"key":"2025120909190353520_j_pp-2016-0006_ref_065_w2aab3b7c23b1b6b1ab2b1c65Aa","doi-asserted-by":"crossref","unstructured":"65. Kuniyasu H, Yoshida K, Sasaki T, Sasahira T, Fujii K, Ohmori H. Conjugated linoleic acid inhibits peritoneal metastasis in human gastrointestinal cancer cells. Int J Cancer 2006;118(3):571\u20136.","DOI":"10.1002\/ijc.21368"},{"key":"2025120909190353520_j_pp-2016-0006_ref_066_w2aab3b7c23b1b6b1ab2b1c66Aa","doi-asserted-by":"crossref","unstructured":"66. Koppe MJ, Oyen WJ, Bleichrodt RP, Verhofstad AA, Goldenberg DM, Boerman OC. Combination therapy using gemcitabine and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin. Cancer Biother Radiopharm 2006;21(5):506\u201314.","DOI":"10.1089\/cbr.2006.21.506"},{"key":"2025120909190353520_j_pp-2016-0006_ref_067_w2aab3b7c23b1b6b1ab2b1c67Aa","doi-asserted-by":"crossref","unstructured":"67. Koppe MJ, Oyen WJG, Bleichrodt RP, Hendriks T, Verhofstad AA, Goldenberg DM, et\u2009al. Combination therapy using the cyclooxygenase-2 inhibitor Parecoxib and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin. Cancer Immunol Immunother 2006;55(1):47\u201355.","DOI":"10.1007\/s00262-005-0704-3"},{"key":"2025120909190353520_j_pp-2016-0006_ref_068_w2aab3b7c23b1b6b1ab2b1c68Aa","doi-asserted-by":"crossref","unstructured":"68. Pourgholami MH, Akhter J, Wang L, Lu Y, Morris DL. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis. Cancer Chemother Pharmacol 2005;55(5):425\u201332.","DOI":"10.1007\/s00280-004-0927-6"},{"key":"2025120909190353520_j_pp-2016-0006_ref_069_w2aab3b7c23b1b6b1ab2b1c69Aa","doi-asserted-by":"crossref","unstructured":"69. Kinuya S, Yokoyama K, Izumo M, Sorita T, Obata T, Mori H, et\u2009al. Locoreginal radioimmunotherapy with Re-186-labeled monoclonal antibody in treating small peritoneal carcinomatosis of colon cancer in mice in comparison with I-131-counterpart. Cancer Lett 2005;219(1):41\u20138.","DOI":"10.1016\/j.canlet.2004.08.033"},{"key":"2025120909190353520_j_pp-2016-0006_ref_070_w2aab3b7c23b1b6b1ab2b1c70Aa","doi-asserted-by":"crossref","unstructured":"70. Zeamari S, Roos E, Stewart FA. Tumour seeding in peritoneal wound sites in relation to growth-factor expression in early granulation tissue. Eur J Cancer 2004;40(9):1431\u201340.","DOI":"10.1016\/j.ejca.2004.01.035"},{"key":"2025120909190353520_j_pp-2016-0006_ref_071_w2aab3b7c23b1b6b1ab2b1c71Aa","unstructured":"71. Koppe MJ, Bleichrodt RP, Soede AC, Verhofstad AA, Goldenberg DM, Oyen WJG, et\u2009al. Biodistribution and therapeutic efficacy of I-125\/131-, Re-186-, Y-88\/90- or Lu-177-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin. J Nucl Med 2004;45(7):1224\u201332."},{"key":"2025120909190353520_j_pp-2016-0006_ref_072_w2aab3b7c23b1b6b1ab2b1c72Aa","doi-asserted-by":"crossref","unstructured":"72. Favoulet P, Benoit L, Osmak L, Polycarpe E, Esquis P, Duvillard C, et\u2009al. Prevention of peritoneal carcinomatosis from colon cancer cell seeding using a pirarubicin solution in rats and nude mice. World J Surg 2004;28(5):451\u20136.","DOI":"10.1007\/s00268-004-6927-1"},{"key":"2025120909190353520_j_pp-2016-0006_ref_073_w2aab3b7c23b1b6b1ab2b1c73Aa","doi-asserted-by":"crossref","unstructured":"73. Koppe E, Soede AC, Pels W, Oyen WJG, Goldenberg DM, Bleichrodt RP, et\u2009al. Experimental radioimmunotherapy of small peritoneal metastases of colorectal origin. Int J Cancer 2003;106(6):965\u201372.","DOI":"10.1002\/ijc.11304"},{"key":"2025120909190353520_j_pp-2016-0006_ref_074_w2aab3b7c23b1b6b1ab2b1c74Aa","doi-asserted-by":"crossref","unstructured":"74. Kinuya S, Li XF, Yokoyama K, Mori H, Shiba K, Watanabe N, et\u2009al. Intraperitoneal radioimmunotherapy in treating peritoneal carcinomatosis of colon cancer in mice compared with systemic radioimmunotherapy. Cancer Sci 2003;94(7):650\u20134.","DOI":"10.1111\/j.1349-7006.2003.tb01498.x"},{"key":"2025120909190353520_j_pp-2016-0006_ref_075_w2aab3b7c23b1b6b1ab2b1c75Aa","doi-asserted-by":"crossref","unstructured":"75. Stoeltzing O, Ahmad SA, Liu W, McCarty MF, Parikh AA, Fan F, et\u2009al. Angiopoietin-1 inhibits tumour growth and ascites formation in a murine model of peritoneal carcinomatosis. Br J Cancer 2002;87(10):1182\u20137.","DOI":"10.1038\/sj.bjc.6600598"},{"key":"2025120909190353520_j_pp-2016-0006_ref_076_w2aab3b7c23b1b6b1ab2b1c76Aa","doi-asserted-by":"crossref","unstructured":"76. Fan YF, Huang ZH. Angiogenesis inhibitor TNP-470 suppresses growth of peritoneal disseminating foci of human colon cancer line Lovo. World J Gastroenterol 2002;8(5):853\u20136.","DOI":"10.3748\/wjg.v8.i5.853"},{"key":"2025120909190353520_j_pp-2016-0006_ref_077_w2aab3b7c23b1b6b1ab2b1c77Aa","doi-asserted-by":"crossref","unstructured":"77. Hubbard SC, Burns JW. Effects of a hyaluronan-based membrane (Seprafilm (R)) on intraperitoneally disseminated human colon cancer cell growth in a nude mouse model. Dis Colon Rectum 2002;45(3):334\u201341.","DOI":"10.1007\/s10350-004-6178-0"},{"key":"2025120909190353520_j_pp-2016-0006_ref_078_w2aab3b7c23b1b6b1ab2b1c78Aa","doi-asserted-by":"crossref","unstructured":"78. Shaheen RM, Ahmad SA, Liu W, Reinmuth N, Jung YD, Tseng WW, et\u2009al. Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors. Br J Cancer 2001;85(4):584\u20139.","DOI":"10.1054\/bjoc.2001.1936"},{"key":"2025120909190353520_j_pp-2016-0006_ref_079_w2aab3b7c23b1b6b1ab2b1c79Aa","doi-asserted-by":"crossref","unstructured":"79. Goto H, Osaki T, Kijima T, Nishino K, Kumagai T, Funakoshi T, et\u2009al. Gene therapy utilizing the Cre\/loxP system selectively suppresses tumor growth of disseminated carcinoembryonic antigen-producing cancer cells. Int J Cancer 2001;94(3):414\u201319.","DOI":"10.1002\/ijc.1474"},{"key":"2025120909190353520_j_pp-2016-0006_ref_080_w2aab3b7c23b1b6b1ab2b1c80Aa","unstructured":"80. Kondo Y, Arii S, Mori A, Furutani M, Chiba T, Imamura M. Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line. Clin Cancer Res 2000;6(2):622\u201330."},{"key":"2025120909190353520_j_pp-2016-0006_ref_081_w2aab3b7c23b1b6b1ab2b1c81Aa","doi-asserted-by":"crossref","unstructured":"81. Crosasso P, Brusa P, Dosio F, Arpicco S, Pacchioni D, Schuber F, et\u2009al. Antitumoral activity of liposomes and immunoliposomes containing 5-fluorouridine prodrugs. J Pharm Sci 1997;86(7):832\u20139.","DOI":"10.1021\/js9604467"},{"key":"2025120909190353520_j_pp-2016-0006_ref_082_w2aab3b7c23b1b6b1ab2b1c82Aa","doi-asserted-by":"crossref","unstructured":"82. Asao T, Nagamachi Y, Morinaga N, Shitara Y, Takenoshita S, Yazawa S. Fucosyl-transferases of the peritoneum contributed to the adhesion of cancer-cells to the mesothelium. Cancer 1995;75(6):1539\u201344.","DOI":"10.1002\/1097-0142(19950315)75:6+<1539::AID-CNCR2820751526>3.0.CO;2-L"},{"key":"2025120909190353520_j_pp-2016-0006_ref_083_w2aab3b7c23b1b6b1ab2b1c83Aa","unstructured":"83. Quadri SM, Malik AB, Tang XZ, Patenia R, Freedman RS, Vriesendorp HM. Preclinical analysis of intraperitoneal administration of in-111-labeled human tumor reactive monoclonal IGM AC6C3-2B12. Cancer Res 1995;55(23):S5736\u2013S5742."},{"key":"2025120909190353520_j_pp-2016-0006_ref_084_w2aab3b7c23b1b6b1ab2b1c84Aa","unstructured":"84. Harlaar NJ, Hesselink JW, de Jong JS, van Dam GM. Bioluminescence as Gold Standard for Validation of Optical Imaging Modalities in Peritoneal Carcinomatosis Animal Models. Eur Surg Res 2010;45(3\u20134):308\u201313."},{"key":"2025120909190353520_j_pp-2016-0006_ref_085_w2aab3b7c23b1b6b1ab2b1c85Aa","unstructured":"85. Mahteme H, Sundin A, Larsson B, Khamis H, Arow K, Graf W. 5-FU uptake in peritoneal metastases after pretreatment with radioimmunotherapy or vasoconstriction: an autoradiographic study in the rat. Anticancer Res 2005;25(2A):917\u201322."},{"key":"2025120909190353520_j_pp-2016-0006_ref_086_w2aab3b7c23b1b6b1ab2b1c86Aa","unstructured":"86. Carpinteri S, Sampurno S, Bernardi M-P, Germann M, Malaterre J, Heriot A, et\u2009al. Inflammation are ameliorated by humidified-warm carbon dioxide insufflation in the mouse. Ann Surg Oncol 2015;22:S1540\u2013S1547."},{"key":"2025120909190353520_j_pp-2016-0006_ref_087_w2aab3b7c23b1b6b1ab2b1c87Aa","doi-asserted-by":"crossref","unstructured":"87. Zhang W, Cui T, Liu L, Wu Q, Sun L, Li L, et\u2009al. Improving anti-tumor activity of curcumin by polymeric micelles in thermosensitive hydrogel system in colorectal peritoneal carcinomatosis model. J Biomed Nanotechnol 2015;11(7):1173\u201382.","DOI":"10.1166\/jbn.2015.2073"},{"key":"2025120909190353520_j_pp-2016-0006_ref_088_w2aab3b7c23b1b6b1ab2b1c88Aa","doi-asserted-by":"crossref","unstructured":"88. Ryan AE, Colleran A, O\u2018Gorman A, O\u2018Flynn L, Pindjacova J, Lohan P, et\u2009al. Targeting colon cancer cell NF-kappa B promotes an anti-tumour M1-like macrophage phenotype and inhibits peritoneal metastasis. Oncogene 2015;34(12):1563\u201374.","DOI":"10.1038\/onc.2014.86"},{"key":"2025120909190353520_j_pp-2016-0006_ref_089_w2aab3b7c23b1b6b1ab2b1c89Aa","doi-asserted-by":"crossref","unstructured":"89. Zhang D, Zheng L, Shi H, Chen X, Wan Y, Zhang H, et\u2009al. Suppression of peritoneal tumorigenesis by placenta-derived mesenchymal stem cells expressing endostatin on colorectal cancer. Int J Med Sci 2014;11(9):870\u20139.","DOI":"10.7150\/ijms.8758"},{"key":"2025120909190353520_j_pp-2016-0006_ref_090_w2aab3b7c23b1b6b1ab2b1c90Aa","doi-asserted-by":"crossref","unstructured":"90. Fan R, Wang Y, Han B, Luo Y, Zhou L, Peng X, et\u2009al. Docetaxel load biodegradable porous microspheres for the treatment of colorectal peritoneal carcinomatosis. Int J Biol Macromol 2014;69:100\u20137.","DOI":"10.1016\/j.ijbiomac.2014.05.026"},{"key":"2025120909190353520_j_pp-2016-0006_ref_091_w2aab3b7c23b1b6b1ab2b1c91Aa","doi-asserted-by":"crossref","unstructured":"91. Sedlacek AL, Gerber SA, Randall TD, van Rooijen N, Frelinger JG, Lord EM. Generation of a dual-functioning antitumor immune response in the peritoneal cavity. Am J Pathol 2013;183(4):1318\u201328.","DOI":"10.1016\/j.ajpath.2013.06.030"},{"key":"2025120909190353520_j_pp-2016-0006_ref_092_w2aab3b7c23b1b6b1ab2b1c92Aa","doi-asserted-by":"crossref","unstructured":"92. Liu L, Wu Q, Ma X, Xiong D, Gong C, Qian Z, et\u2009al. Camptothecine encapsulated composite drug delivery system for colorectal peritoneal carcinomatosis therapy: Biodegradable microsphere in thermosensitive hydrogel. Colloids Surf B Biointerfaces 2013;106:93\u2013101.","DOI":"10.1016\/j.colsurfb.2013.01.047"},{"key":"2025120909190353520_j_pp-2016-0006_ref_093_w2aab3b7c23b1b6b1ab2b1c93Aa","doi-asserted-by":"crossref","unstructured":"93. Li W, Wu K, Zhao E, Shi L, Li R, Zhang P, et\u2009al. HMGB1 recruits myeloid derived suppressor cells to promote peritoneal dissemination of colon cancer after resection. Biochem Biophys Res Commun 2013;436(2):156\u201361.","DOI":"10.1016\/j.bbrc.2013.04.109"},{"key":"2025120909190353520_j_pp-2016-0006_ref_094_w2aab3b7c23b1b6b1ab2b1c94Aa","doi-asserted-by":"crossref","unstructured":"94. Yao Y, Su X, Xie Y, Wang Y, Kang T, Gou L, Yi C, et\u2009al. Synthesis characterization, and antitumor evaluation of the albumin-SN38 conjugate. Anti-Cancer Drugs 2013;24(3):270\u20137.","DOI":"10.1097\/CAD.0b013e32835c3543"},{"key":"2025120909190353520_j_pp-2016-0006_ref_095_w2aab3b7c23b1b6b1ab2b1c95Aa","doi-asserted-by":"crossref","unstructured":"95. Yu M, Niu Z-M, Wei Y-Q. Effective response of the peritoneum microenvironment to peritoneal and systemic metastasis from colorectal carcinoma. Asian Pac J Cancer Prev 2013;14(12):7289\u201394.","DOI":"10.7314\/APJCP.2013.14.12.7289"},{"key":"2025120909190353520_j_pp-2016-0006_ref_096_w2aab3b7c23b1b6b1ab2b1c96Aa","doi-asserted-by":"crossref","unstructured":"96. Lee IK, VanSaun MN, Shim JH, Matrisian LM, Gorden DL. Increased metastases are associated with inflammation and matrix metalloproteinase-9 activity at incision sites in a murine model of peritoneal dissemination of colorectal cancer. J Surg Res 2013;180(2):252\u20139.","DOI":"10.1016\/j.jss.2012.04.074"},{"key":"2025120909190353520_j_pp-2016-0006_ref_097_w2aab3b7c23b1b6b1ab2b1c97Aa","doi-asserted-by":"crossref","unstructured":"97. Wu QJ, Gong CY, Luo ST, Zhang DM, Zhang S, Shi HS, et\u2009al. AAV-mediated human PEDF inhibits tumor growth and metastasis in murine colorectal peritoneal carcinomatosis model. BMC Cancer 2012;12:129.","DOI":"10.1186\/1471-2407-12-129"},{"key":"2025120909190353520_j_pp-2016-0006_ref_098_w2aab3b7c23b1b6b1ab2b1c98Aa","doi-asserted-by":"crossref","unstructured":"98. Lehmann K, Rickenbacher A, Jang J-H, Oberkofler CE, Vonlanthen R, von Boehmer L, et\u2009al. New insight into hyperthermic intraperitoneal chemotherapy induction of oxidative stress dramatically enhanced tumor killing in in vitro and in vivo models. Ann Surg 2012;256(5):730\u20138.","DOI":"10.1097\/SLA.0b013e3182737517"},{"key":"2025120909190353520_j_pp-2016-0006_ref_099_w2aab3b7c23b1b6b1ab2b1c99Aa","unstructured":"99. Tsai C-C, Chang C-H, Chen L-C, Chang Y-J, Lan K-L, Wu Y-H, et\u2009al. Biodistribution and pharmacokinetics of Re-188-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice. Int J Nanomed 2011;6:2607\u201319."},{"key":"2025120909190353520_j_pp-2016-0006_ref_100_w2aab3b7c23b1b6b1ab2b1d100Aa","doi-asserted-by":"crossref","unstructured":"100. Puskas J, Skrombolas D, Sedlacek A, Lord E, Sullivan M, Frelinger J. Development of an attenuated interleukin-2 fusion protein that can be activated by tumour-expressed proteases. Immunology 2011;133(2):206\u201320.","DOI":"10.1111\/j.1365-2567.2011.03428.x"},{"key":"2025120909190353520_j_pp-2016-0006_ref_101_w2aab3b7c23b1b6b1ab2b1d101Aa","doi-asserted-by":"crossref","unstructured":"101. Nishizaki C, Nishikawa M, Yata T, Yamada T, Takahashi Y, Oku M, et\u2009al. Inhibition of surgical trauma-enhanced peritoneal dissemination of tumor cells by human catalase derivatives in mice. Free Radic Biol Med 2011;51(3):773\u20139.","DOI":"10.1016\/j.freeradbiomed.2011.05.025"},{"key":"2025120909190353520_j_pp-2016-0006_ref_102_w2aab3b7c23b1b6b1ab2b1d102Aa","doi-asserted-by":"crossref","unstructured":"102. Dai M, Xu X, Song J, Fu S, Gou M, Luo F, et\u2009al. Preparation of camptothecin-loaded PCEC microspheres for the treatment of colorectal peritoneal carcinomatosis and tumor growth in mice. Cancer Lett 2011;312(2):189\u201396.","DOI":"10.1016\/j.canlet.2011.08.007"},{"key":"2025120909190353520_j_pp-2016-0006_ref_103_w2aab3b7c23b1b6b1ab2b1d103Aa","doi-asserted-by":"crossref","unstructured":"103. Wang Y, Gong C, Yang L, Wu Q, Shi S, Shi H, et\u2009al. 5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice. Bmc Cancer 2010;10:402.","DOI":"10.1186\/1471-2407-10-402"},{"key":"2025120909190353520_j_pp-2016-0006_ref_104_w2aab3b7c23b1b6b1ab2b1d104Aa","doi-asserted-by":"crossref","unstructured":"104. Tanaka H, Shinto O, Yashiro M, Yamazoe S, Iwauchi T, Muguruma K, et\u2009al. Transforming growth factor beta signaling inhibitor, SB-431542, induces maturation of dendritic cells and enhances anti-tumor activity. Oncol Rep 2010;24(6):1637\u201343.","DOI":"10.3892\/or_00001028"},{"key":"2025120909190353520_j_pp-2016-0006_ref_105_w2aab3b7c23b1b6b1ab2b1d105Aa","doi-asserted-by":"crossref","unstructured":"105. Keese M, Yagublu V, Schwenke K, Post S, Bastiaens P. Fluorescence lifetime imaging microscopy of chemotherapy-induced apoptosis resistance in a syngenic mouse tumor model. Int J Cancer 2010;126(1):104\u201313.","DOI":"10.1002\/ijc.24730"},{"key":"2025120909190353520_j_pp-2016-0006_ref_106_w2aab3b7c23b1b6b1ab2b1d106Aa","doi-asserted-by":"crossref","unstructured":"106. Kulu Y, Dorfman JD, Kuruppu D, Fuchs BC, Goodwin JM, Fujii T, et al. Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice. Cancer Gene Ther 2009;16(4):291\u20137.","DOI":"10.1038\/cgt.2008.83"},{"key":"2025120909190353520_j_pp-2016-0006_ref_107_w2aab3b7c23b1b6b1ab2b1d107Aa","doi-asserted-by":"crossref","unstructured":"107. Keese M, Gasimova L, Schwenke K, Yagublu V, Shang E, Faissner R, et\u2009al. Doxorubicin and mitoxantrone drug eluting beads for the treatment of experimental peritoneal carcinomatosis in colorectal cancer. Int J Cancer 2009;124(11):2701\u20138.","DOI":"10.1002\/ijc.24211"},{"key":"2025120909190353520_j_pp-2016-0006_ref_108_w2aab3b7c23b1b6b1ab2b1d108Aa","doi-asserted-by":"crossref","unstructured":"108. Lan K-L, Yen S-H, Liu R-S, Shih H-L, Tseng F-W, Lan K-H. Mutant Bik gene transferred by cationic liposome inhibits peritoneal disseminated murine colon cancer. Clin Exp Metastasis 2007;24(6):461\u201370.","DOI":"10.1007\/s10585-007-9083-9"},{"key":"2025120909190353520_j_pp-2016-0006_ref_109_w2aab3b7c23b1b6b1ab2b1d109Aa","doi-asserted-by":"crossref","unstructured":"109. Hyoudou K, Nishikawa M, Ikemura M, Kobayashi Y, Mendelsohn A, Miyazaki N, et\u2009al. Cationized catalase-loaded hydrogel for growth inhibition of peritoneally disseminated tumor cells. J Controlled Release 2007;122(2):151\u20138.","DOI":"10.1016\/j.jconrel.2007.07.002"},{"key":"2025120909190353520_j_pp-2016-0006_ref_110_w2aab3b7c23b1b6b1ab2b1d110Aa","unstructured":"110. Dvir-Ginzberg M, Konson A, Cohen S, Agbaria R. Entrapment of retroviral vector producer cells in three-dimensional alginate scaffolds for potential use in cancer gene therapy. J Biomed Mater Res Part B Appl Biomater 2007;80B(1):59\u201366."},{"key":"2025120909190353520_j_pp-2016-0006_ref_111_w2aab3b7c23b1b6b1ab2b1d111Aa","unstructured":"111. Hyoudou K, Nishikawa M, Kobayashi Y, Kuramoto Y, Yamashita F, Hashida M. Inhibition of adhesion and proliferation of peritoneally disseminated tumor cells by pegylated catalase. Clin Exp Metastasis 2006;23(5\u20136):269\u201378."},{"key":"2025120909190353520_j_pp-2016-0006_ref_112_w2aab3b7c23b1b6b1ab2b1d112Aa","doi-asserted-by":"crossref","unstructured":"112. Helguera G, Rodriguez JA, Penichet ML. Cytokines fused to antibodies and their combinations as therapeutic agents against different peritoneal HER2\/neu expressing tumors. Mol Cancer Ther 2006;5(4):1029\u201340.","DOI":"10.1158\/1535-7163.MCT-05-0488"},{"key":"2025120909190353520_j_pp-2016-0006_ref_113_w2aab3b7c23b1b6b1ab2b1d113Aa","doi-asserted-by":"crossref","unstructured":"113. Yu HK, Ahn JH, Lee HJ, Lee SK, Hong SW, Yoon Y, et\u2009al. Expression of human apolipoprotein(a) kringles in colon cancer cells suppresses angiogenesis-dependent tumor growth and peritoneal dissemination. J Gene Med 2005;7(1):39\u201349.","DOI":"10.1002\/jgm.638"},{"key":"2025120909190353520_j_pp-2016-0006_ref_114_w2aab3b7c23b1b6b1ab2b1d114Aa","doi-asserted-by":"crossref","unstructured":"114. Yamaguchi K, Hirabayashi Y, Suematsu T, Shiraishi N, Adachi Y, Kitano S. Hyaluronic acid secretion during carbon dioxide pneumoperitoneum and its association with port-site metastasis in a murine model. Surg Endosc 2001;15(1):59\u201362.","DOI":"10.1007\/s004640000238"},{"key":"2025120909190353520_j_pp-2016-0006_ref_115_w2aab3b7c23b1b6b1ab2b1d115Aa","doi-asserted-by":"crossref","unstructured":"115. Miyata T, Yamamoto S, Sakamoto K, Morishita R, Kaneda Y. Novel immunotherapy for peritoneal dissemination of murine colon cancer with macrophage inflammatory protein-1 beta mediated by a tumor-specific vector, HVJ cationic liposomes. Cancer Gene Ther 2001;8(11):852\u201360.","DOI":"10.1038\/sj.cgt.7700384"},{"key":"2025120909190353520_j_pp-2016-0006_ref_116_w2aab3b7c23b1b6b1ab2b1d116Aa","doi-asserted-by":"crossref","unstructured":"116. Moreno EF, Nelson H, Carugno F, Hodge D, Mozes G, Thompson GB. Effects of laparoscopy on tumor growth. Surg Laparosc Endosc Percutan Tech 2000;10(5):296\u2013301.","DOI":"10.1097\/00129689-200010000-00007"},{"key":"2025120909190353520_j_pp-2016-0006_ref_117_w2aab3b7c23b1b6b1ab2b1d117Aa","unstructured":"117. Maruyama M, Nagahama T, Yuasa Y. Intraperitoneal versus intravenous CPT-11 for peritoneal seeding and liver metastasis. Anticancer Res 1999;19(5B):4187\u201391."},{"key":"2025120909190353520_j_pp-2016-0006_ref_118_w2aab3b7c23b1b6b1ab2b1d118Aa","doi-asserted-by":"crossref","unstructured":"118. Guichard S, Chatelut E, Lochon I, Bugat R, Mahjoubi M, Canal P. Comparison of the pharmacokinetics and efficacy of irinotecan after administration by the intravenous versus intraperitoneal route in mice. Cancer Chemother Pharmacol 1998;42(2):165\u201370.","DOI":"10.1007\/s002800050801"},{"key":"2025120909190353520_j_pp-2016-0006_ref_119_w2aab3b7c23b1b6b1ab2b1d119Aa","unstructured":"119. Kurihara M, Uchida J, Fujioka A, Kato T, Ohshimo H, Abe M, et\u2009al. Effect of combination therapy with UFT plus cisplatin (UFTP) on the survival of mice in the experimental model for wide-spread metastasis in the peritoneal cavity of gastrointestinal cancer using colon 26 PMF-15 cells. Anticancer Res 1997;17(3C):2217\u201320."},{"key":"2025120909190353520_j_pp-2016-0006_ref_120_w2aab3b7c23b1b6b1ab2b1d120Aa","unstructured":"120. Gutman M, Szold A, Ravid A, Lazauskas T, Merimsky O, Klausner JM. Failure of thalidomide to inhibit tumor growth and angiogenesis in vivo. Anticancer Res 1996;16(6B):3673\u20137."},{"key":"2025120909190353520_j_pp-2016-0006_ref_121_w2aab3b7c23b1b6b1ab2b1d121Aa","doi-asserted-by":"crossref","unstructured":"121. Mayhew E, Cimino M, Klemperer J, Lazo R, Wiernikowski J, Arbuck S. Free and liposomal doxorubicin treatment of intraperitoneal colon-26 tumor \u2013 therapeutic and pharmacological studies. Sel Cancer Ther 1990;6(4):193\u2013209.","DOI":"10.1089\/sct.1990.6.193"},{"key":"2025120909190353520_j_pp-2016-0006_ref_122_w2aab3b7c23b1b6b1ab2b1d122Aa","unstructured":"122. Imano M, Itoh T, Satou T, Kido A, Tsubaki M, Yasuda A, et\u2009al.. Establishment of a Novel Model of Peritoneal Carcinomatosis of the Peritoneal Extension Type. Anticancer Res 2013;33(4):1439\u201346."},{"key":"2025120909190353520_j_pp-2016-0006_ref_123_w2aab3b7c23b1b6b1ab2b1d123Aa","unstructured":"123. Eriksson SE, Ohlsson T, Nilsson R, Repeated TJ. Radioimmunotherapy with Lu-177-DOTA-BR96 in a Syngeneic Rat Colon Carcinoma Model. Cancer Biother Radiopharm 2012;27(2):134\u201340."},{"key":"2025120909190353520_j_pp-2016-0006_ref_124_w2aab3b7c23b1b6b1ab2b1d124Aa","doi-asserted-by":"crossref","unstructured":"124. Moretto J, Chauffert B, Ghiringhelli F, Aldrich-Wright JR, Bouyer F. Discrepancy between in vitro and in vivo antitumor effect of a new platinum(II) metallointercalator. Invest New Drugs 2011;29(6):1164\u201376.","DOI":"10.1007\/s10637-010-9461-z"},{"key":"2025120909190353520_j_pp-2016-0006_ref_125_w2aab3b7c23b1b6b1ab2b1d125Aa","doi-asserted-by":"crossref","unstructured":"125. Klaver YL, Hendriks T, Lomme RM, Rutten HJ, Bleichrodt RP, de Hingh IH. Hyperthermia and intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis: an experimental study. Ann Surg 2011;254(1):125\u201330.","DOI":"10.1097\/SLA.0b013e3182197102"},{"key":"2025120909190353520_j_pp-2016-0006_ref_126_w2aab3b7c23b1b6b1ab2b1d126Aa","doi-asserted-by":"crossref","unstructured":"126. Serafino A, Zonfrillo M, Andreola F, Psaila R, Mercuri L, Moroni N, et\u2009al. CD44-Targeting for Antitumor Drug Delivery: A New SN-38-Hyaluronan Bioconjugate for Locoregional Treatment of Peritoneal Carcinomatosis. Curr Cancer Drug Targets 2011;11(5):572\u201385.","DOI":"10.2174\/156800911795655976"},{"key":"2025120909190353520_j_pp-2016-0006_ref_127_w2aab3b7c23b1b6b1ab2b1d127Aa","doi-asserted-by":"crossref","unstructured":"127. Klaver YL, Hendriks T, Lomme RM, Rutten HJ, Bleichrodt RP, de Hingh IH. Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model. Br J Surg 2010;97(12):1874\u201380.","DOI":"10.1002\/bjs.7249"},{"key":"2025120909190353520_j_pp-2016-0006_ref_128_w2aab3b7c23b1b6b1ab2b1d128Aa","doi-asserted-by":"crossref","unstructured":"128. van der Bij GJ, Bogels M, Oosterling SJ, Kroon J, Schuckmann DTM, de Vries HE, et\u2009al. Tumor infiltrating macrophages reduce development of peritoneal colorectal carcinoma metastases. Cancer Lett 2008;262(1):77\u201386.","DOI":"10.1016\/j.canlet.2007.11.040"},{"key":"2025120909190353520_j_pp-2016-0006_ref_129_w2aab3b7c23b1b6b1ab2b1d129Aa","doi-asserted-by":"crossref","unstructured":"129. Taguchi E, Nakamura K, Miura T, Shibuya M, Isoe T. Anti-tumor activity and tumor vessel normalization by the vascular endothelial growth factor receptor tyrosine kinase inhibitor KRN951 in a rat peritoneal disseminated tumor model. Cancer Sci 2008;99(3):623\u201330.","DOI":"10.1111\/j.1349-7006.2007.00724.x"},{"key":"2025120909190353520_j_pp-2016-0006_ref_130_w2aab3b7c23b1b6b1ab2b1d130Aa","doi-asserted-by":"crossref","unstructured":"130. Oosterling SJ, van der Bij GJ, Boegels M, ten Raa S, Post JA, Meijer GA, et\u2009al. Anti-beta 1 integrin antibody reduces surgery-induced adhesion of colon carcinoma cells to traumatized peritoneal surfaces. Ann Surg 2008;247(1):85\u201394.","DOI":"10.1097\/SLA.0b013e3181588583"},{"key":"2025120909190353520_j_pp-2016-0006_ref_131_w2aab3b7c23b1b6b1ab2b1d131Aa","doi-asserted-by":"crossref","unstructured":"131. Aarts F, Hendriks T, Boerman OC, Oyen WJG, Bleichrodt RP. Hyperthermia and fibrinolytic therapy do not improve the beneficial effect of radioimmunotherapy following cytoreductive surgery in rats with peritoneal carcinomatosis of colorectal origin. Cancer Biother Radiopharm 2008;23(3):301\u20139.","DOI":"10.1089\/cbr.2007.0455"},{"key":"2025120909190353520_j_pp-2016-0006_ref_132_w2aab3b7c23b1b6b1ab2b1d132Aa","doi-asserted-by":"crossref","unstructured":"132. Otto J, Jansen PL, Lucas S, Schumpelick V, Jansen M. Reduction of peritoneal carcinomatosis by intraperitoneal administration of phospholipids in rats. BMC Cancer 2007;7:104.","DOI":"10.1186\/1471-2407-7-104"},{"key":"2025120909190353520_j_pp-2016-0006_ref_133_w2aab3b7c23b1b6b1ab2b1d133Aa","doi-asserted-by":"crossref","unstructured":"133. Hribaschek A, Meyer F, Schneider-Stock R, Pross M, Ridwelski K, Lippert H. Comparison of intraperitoneal with intravenous administration of taxol in experimental peritoneal carcinomatosis. Chemotherapy 2007;53(6):410\u201317.","DOI":"10.1159\/000110005"},{"key":"2025120909190353520_j_pp-2016-0006_ref_134_w2aab3b7c23b1b6b1ab2b1d134Aa","doi-asserted-by":"crossref","unstructured":"134. Bobrich E, Braumann C, Opitz I, Menenakos C, Kristiansen G, Jacobi CA. Influence of intraperitoneal application of taurolidine\/heparin on expression of adhesion molecules and colon cancer in rats undergoing laparoscopy. J Surg Res 2007;137(1):75\u201382.","DOI":"10.1016\/j.jss.2006.07.013"},{"key":"2025120909190353520_j_pp-2016-0006_ref_135_w2aab3b7c23b1b6b1ab2b1d135Aa","doi-asserted-by":"crossref","unstructured":"135. Aarts F, Koppe MJ, Hendriks T, vanEerd JEM, Oyen WJG, Boerman OC, Bleichrodt RP. Timing of adjuvant radioimmunotherapy after cytoreductive surgery in experimental peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 2007;14(2):533\u201340.","DOI":"10.1245\/s10434-006-9247-x"},{"key":"2025120909190353520_j_pp-2016-0006_ref_136_w2aab3b7c23b1b6b1ab2b1d136Aa","doi-asserted-by":"crossref","unstructured":"136. Aarts F, Hendriks T, Boerman OC, Koppe MJ, Oyen WJG, Bleichrodt RP. A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats. Ann Surg Oncol 2007;14(11):3274\u201382.","DOI":"10.1245\/s10434-007-9509-2"},{"key":"2025120909190353520_j_pp-2016-0006_ref_137_w2aab3b7c23b1b6b1ab2b1d137Aa","doi-asserted-by":"crossref","unstructured":"137. Pelz JOW, Doerfer J, Dimmler A, Hohenberger W, Meyer T. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations. BMC Cancer 2006;6:162.","DOI":"10.1186\/1471-2407-6-162"},{"key":"2025120909190353520_j_pp-2016-0006_ref_138_w2aab3b7c23b1b6b1ab2b1d138Aa","doi-asserted-by":"crossref","unstructured":"138. Oosterling SJ, van der Bij GJ, Bogels M, van der Sijp JRM, Beelen RHJ, Meijer S, et\u2009al.. Insufficient ability of omental milky spots to prevent peritoneal tumor outgrowth supports omentectomy in minimal residual disease. Cancer Immunol Immunother 2006;55(9):1043\u201351.","DOI":"10.1007\/s00262-005-0101-y"},{"key":"2025120909190353520_j_pp-2016-0006_ref_139_w2aab3b7c23b1b6b1ab2b1d139Aa","doi-asserted-by":"crossref","unstructured":"139. Nestler G, Schulz HU, Tautenhahn J, Kuhn R, Kruger S, Lippert H, et\u2009al.. Effects of the angiogenesis inhibitor angiostatin on the growth of CC531 colon carcinoma cells in vitro and in a laparoscopic animal model of peritoneal carcinomatosis. Int J Colorectal Dis 2006;21(4):314\u201320.","DOI":"10.1007\/s00384-005-0040-2"},{"key":"2025120909190353520_j_pp-2016-0006_ref_140_w2aab3b7c23b1b6b1ab2b1d140Aa","unstructured":"140. Koppe MJ, Hendriks T, Boerman OC, Oyen WJG, Bleichrodt RP. Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis. J Nucl Med 2006;47(11):1867\u201374."},{"key":"2025120909190353520_j_pp-2016-0006_ref_141_w2aab3b7c23b1b6b1ab2b1d141Aa","doi-asserted-by":"crossref","unstructured":"141. Hribaschek A, Kuhn R, Pross M, Meyer F, Fahlke J, Ridwelski K, et\u2009al. Intraperitoneal versus intravenous CPT-11 given intra- and postoperatively for peritoneal carcinomatosis in a rat model. Surg Today 2006;36(1):57\u201362.","DOI":"10.1007\/s00595-004-3096-7"},{"key":"2025120909190353520_j_pp-2016-0006_ref_142_w2aab3b7c23b1b6b1ab2b1d142Aa","doi-asserted-by":"crossref","unstructured":"142. van den Tol P, ten Raa S, van Grevenstein H, Marquet R, van Eijck C, Jeekel H. Icodextrin reduces postoperative adhesion formation in rats without affecting peritoneal metastasis. Surgery 2005;137(3):348\u201354.","DOI":"10.1016\/j.surg.2004.06.001"},{"key":"2025120909190353520_j_pp-2016-0006_ref_143_w2aab3b7c23b1b6b1ab2b1d143Aa","doi-asserted-by":"crossref","unstructured":"143. Oosterling SJ, van der Bij GJ, Meijer GA, Tuk CW, van Garderen E, van Rooijen N, et\u2009al. Macrophages direct tumour histology and clinical outcome in a colon cancer model. J Pathol 2005;207(2):147\u201355.","DOI":"10.1002\/path.1830"},{"key":"2025120909190353520_j_pp-2016-0006_ref_144_w2aab3b7c23b1b6b1ab2b1d144Aa","doi-asserted-by":"crossref","unstructured":"144. Alkhamesi NA, Ziprin P, Pfistermuller K, Peck DH, Darzi AWICAM-. 1 mediated peritoneal carcinomatosis, a target for therapeutic intervention. Clin Exp Metastasis 2005;22(6):449\u201359.","DOI":"10.1007\/s10585-005-2893-8"},{"key":"2025120909190353520_j_pp-2016-0006_ref_145_w2aab3b7c23b1b6b1ab2b1d145Aa","doi-asserted-by":"crossref","unstructured":"145. Alkhamesi NA, Ridgway PF, Ramwell A, McCullough PW, Peck DH, Darzi AW. Peritoneal nebulizer - A novel technique for delivering intraperitoneal therapeutics in laparoscopic surgery to prevent locoregional recurrence. Surg Endosc 2005;19(8):1142\u20136.","DOI":"10.1007\/s00464-004-2214-3"},{"key":"2025120909190353520_j_pp-2016-0006_ref_146_w2aab3b7c23b1b6b1ab2b1d146Aa","doi-asserted-by":"crossref","unstructured":"146. Mahteme H, Larsson B, Sundin A, Khamis H, Graf W. Uptake of 5-fluorouracil (5-FU) in peritoneal metastases in relation to the route of drug administration and tumour debulking surgery: an autoradiographic study in the rat. Eur J Cancer 2004;40(1):142\u20137.","DOI":"10.1016\/S0959-8049(03)00667-1"},{"key":"2025120909190353520_j_pp-2016-0006_ref_147_w2aab3b7c23b1b6b1ab2b1d147Aa","doi-asserted-by":"crossref","unstructured":"147. Zayyan KS, Christie-Brown JS, Van Noorden S, Yiu CY, Sellu DP, Mathie RT. Rapid flow carbon dioxide laparoscopy disperses cancer cells into the peritoneal cavity but not the port sites in a new rat model. Surg Endosc 2003;17(2):273\u20137.","DOI":"10.1007\/s00464-002-8824-8"},{"key":"2025120909190353520_j_pp-2016-0006_ref_148_w2aab3b7c23b1b6b1ab2b1d148Aa","doi-asserted-by":"crossref","unstructured":"148. Opitz I, van der Veen HC, Braumann C, Ablassmaier B, Fuhrer K, Jacobi CA. The influence of adhesion prophylactic substances and taurolidine\/heparin on local recurrence and intraperitoneal tumor growth after laparoscopic-assisted bowel resection of colon carcinoma in a rat model. Surg Endosc 2003;17(7):1098\u2013104.","DOI":"10.1007\/s00464-002-9161-7"},{"key":"2025120909190353520_j_pp-2016-0006_ref_149_w2aab3b7c23b1b6b1ab2b1d149Aa","doi-asserted-by":"crossref","unstructured":"149. Hribaschek A, Pross M, Kuhn R, Kruger S, Ridwelski K, Halangk W, et\u2009al. Prevention and treatment of peritoneal carcinomatosis in experimental investigations with CPT-11 and oxaliplatin. Anti-Cancer Drugs 2002;13(6):605\u201314.","DOI":"10.1097\/00001813-200207000-00007"},{"key":"2025120909190353520_j_pp-2016-0006_ref_150_w2aab3b7c23b1b6b1ab2b1d150Aa","doi-asserted-by":"crossref","unstructured":"150. Gahlen J, Prosst RL, Pietschmann M, Haase T, Rheinwald M, Skopp G, et\u2009al. Laparoscopic fluorescence diagnosis for intraabdominal fluorescence targeting of peritoneal carcinosis experimental studies. Ann Surg 2002;235(2):252\u201360.","DOI":"10.1097\/00000658-200202000-00014"},{"key":"2025120909190353520_j_pp-2016-0006_ref_151_w2aab3b7c23b1b6b1ab2b1d151Aa","doi-asserted-by":"crossref","unstructured":"151. van den Tol MP, Haverlag R, van Rossen MEE, Bonthuis F, Marquet RL, Jeekel J. Glove powder promotes adhesion formation and facilitates tumour cell adhesion and growth. Br J Surg 2001;88(9):1258\u201363.","DOI":"10.1046\/j.0007-1323.2001.01846.x"},{"key":"2025120909190353520_j_pp-2016-0006_ref_152_w2aab3b7c23b1b6b1ab2b1d152Aa","doi-asserted-by":"crossref","unstructured":"152. Tan B, Wang JH, Wu QD, Kirwan WO, Redmond HP. Sodium hyaluronate enhances colorectal tumour cell metastatic potential in vitro and in vivo. Br J Surg 2001;88(2):246\u201350.","DOI":"10.1046\/j.1365-2168.2001.01664.x"},{"key":"2025120909190353520_j_pp-2016-0006_ref_153_w2aab3b7c23b1b6b1ab2b1d153Aa","doi-asserted-by":"crossref","unstructured":"153. Hoffstetter W, Ortega A, Chiang M, Paik P, Beart RW. Effects of topical tumoricidal agents on port-site recurrence of colon cancer: An experimental study in rats. J Laparoendosc Adv Surg Tech A 2001;11(1):9\u201312.","DOI":"10.1089\/10926420150502878"},{"key":"2025120909190353520_j_pp-2016-0006_ref_154_w2aab3b7c23b1b6b1ab2b1d154Aa","unstructured":"154. Miyoshi C, Ohshima N. Vascular endothelial growth factor (VEGF) expression regulates angiogenesis accompanying tumor growth in a peritoneal disseminated tumor model. In Vivo 2001;15(3):233\u20138."},{"key":"2025120909190353520_j_pp-2016-0006_ref_155_w2aab3b7c23b1b6b1ab2b1d155Aa","doi-asserted-by":"crossref","unstructured":"155. McCourt M, Wang JH, Sookhai S, Redmond HP. Taurolidine inhibits tumor cell growth in vitro and in vivo. Ann Surg Oncol 2000;7(9):685\u201391.","DOI":"10.1007\/s10434-000-0685-6"},{"key":"2025120909190353520_j_pp-2016-0006_ref_156_w2aab3b7c23b1b6b1ab2b1d156Aa","doi-asserted-by":"crossref","unstructured":"156. Hofstetter W, Ortega A, Chiang M, Brown B, Paik P, Youn P, et\u2009al. Abdominal insufflation does not cause hematogenous spread of colon cancer. J Laparoendosc Adv Surg Tech A 2000;10(1):1\u20134.","DOI":"10.1089\/lap.2000.10.1"},{"key":"2025120909190353520_j_pp-2016-0006_ref_157_w2aab3b7c23b1b6b1ab2b1d157Aa","doi-asserted-by":"crossref","unstructured":"157. van Rossen MEE, Stoop MPO, Hofland LJ, van Koetsveld PM, Bonthuis F, Jeekel J, et\u2009al. Red blood cells inhibit tumour cell adhesion to the peritoneum. Br J Surg 1999;86(4):509\u201313.","DOI":"10.1046\/j.1365-2168.1999.01050.x"},{"key":"2025120909190353520_j_pp-2016-0006_ref_158_w2aab3b7c23b1b6b1ab2b1d158Aa","doi-asserted-by":"crossref","unstructured":"158. Onier N, Hilpert S, Arnould L, Saint-Giorgio V, Davies JG, Bauer J, et\u2009al. Cure of colon cancer metastasis in rats with the new lipid A OM 174. Apoptosis of tumor cells and immunization of rats. Clin Exp Metastasis 1999;17(4):299\u2013306.","DOI":"10.1023\/A:1006663017149"},{"key":"2025120909190353520_j_pp-2016-0006_ref_159_w2aab3b7c23b1b6b1ab2b1d159Aa","doi-asserted-by":"crossref","unstructured":"159. Jacobi CA, Wildbrett P, Volk T, Muller JM. Influence of different gases and intraperitoneal instillation of antiadherent or cytotoxic agents on peritoneal tumor cell growth and implantation with laparoscopic surgery in a rat model. Surg Endosc 1999;13(10):1021\u20135.","DOI":"10.1007\/s004649901160"},{"key":"2025120909190353520_j_pp-2016-0006_ref_160_w2aab3b7c23b1b6b1ab2b1d160Aa","doi-asserted-by":"crossref","unstructured":"160. Jacobi CA, Peter FJ, Wenger FA, Ordemann J, Muller JM. New therapeutic strategies to avoid intra- and extraperitoneal metastases during laparoscopy: Results of a tumor model in the rat. Dig Surg 1999;16(5):393\u20139.","DOI":"10.1159\/000018754"},{"key":"2025120909190353520_j_pp-2016-0006_ref_161_w2aab3b7c23b1b6b1ab2b1d161Aa","doi-asserted-by":"crossref","unstructured":"161. Gahlen J, Stern J, Laubach HH, Pietschmann M, Herfarth C. Improving diagnostic staging laparoscopy using intraperitoneal lavage of delta-aminolevulinic acid (ALA) for laparoscopic fluorescence diagnosis. Surgery 1999;126(3):469\u201373.","DOI":"10.1016\/S0039-6060(99)70086-3"},{"key":"2025120909190353520_j_pp-2016-0006_ref_162_w2aab3b7c23b1b6b1ab2b1d162Aa","unstructured":"162. Gahlen J, Laubach HH, Stern J, Pietschmann M, Herfarth C. Evaluation of laparoscopic fluorescencevisualization of peritoneal carcinosis with delta-aminolevulinic acid (ALA). Langenbeck Arch Surg 1999, Suppl 1:717\u201321."},{"key":"2025120909190353520_j_pp-2016-0006_ref_163_w2aab3b7c23b1b6b1ab2b1d163Aa","doi-asserted-by":"crossref","unstructured":"163. Lundberg O, Kristoffersson A. Effect of pneumoperitoneum induced by carbon dioxide and air on tumor load in a rat model. World J Surg 1998;22(5):470\u20132.","DOI":"10.1007\/s002689900418"},{"key":"2025120909190353520_j_pp-2016-0006_ref_164_w2aab3b7c23b1b6b1ab2b1d164Aa","doi-asserted-by":"crossref","unstructured":"164. Veenhuizen RB, Ruevekamp MC, Oppelaar H, Helmerhorst TJM, Kenemans P, Stewart FA. Foscan-mediated photodynamic therapy for a peritoneal-cancer model: Drug distribution and efficacy studies. Int J Cancer 1997;73(2):230\u20135.","DOI":"10.1002\/(SICI)1097-0215(19971009)73:2<230::AID-IJC12>3.0.CO;2-J"},{"key":"2025120909190353520_j_pp-2016-0006_ref_165_w2aab3b7c23b1b6b1ab2b1d165Aa","doi-asserted-by":"crossref","unstructured":"165. Jacobi CA, Ordemann J, Bohm B, Zieren HU, Sabat R, Muller JM. Inhibition of peritoneal tumor cell growth and implantation in laparoscopic surgery in a rat model. Am J Surg 1997;174(3):359\u201363.","DOI":"10.1016\/S0002-9610(97)00099-8"},{"key":"2025120909190353520_j_pp-2016-0006_ref_166_w2aab3b7c23b1b6b1ab2b1d166Aa","doi-asserted-by":"crossref","unstructured":"166. Jacquet P, Stuart OA, Dalton R, Chang D, Sugarbaker PH. Effect of intraperitoneal chemotherapy and fibrinolytic therapy on tumor implantation in wound sites. J Surg Oncol 1996;62(2):128\u201334.","DOI":"10.1002\/(SICI)1096-9098(199606)62:2<128::AID-JSO9>3.0.CO;2-A"},{"key":"2025120909190353520_j_pp-2016-0006_ref_167_w2aab3b7c23b1b6b1ab2b1d167Aa","doi-asserted-by":"crossref","unstructured":"167. Bouvy ND, Marquet RL, Jeekel H, Bonjer HJ. Impact of gas(less) laparoscopy and laparotomy on peritoneal tumor growth and abdominal wall metastases. Ann Surg 1996;224(6):694\u2013701.","DOI":"10.1097\/00000658-199612000-00005"},{"key":"2025120909190353520_j_pp-2016-0006_ref_168_w2aab3b7c23b1b6b1ab2b1d168Aa","unstructured":"168. Onier N, Lejeune P, Martin M, Hammann A, Bauer J, Hirt P, et\u2009al. Involvement of T-lymphocytes in curative effect of a new immunomodulator OM-163 on rat colon-cancer metastases. Eur J Cancer 1993;29A(14):2003\u20139."},{"key":"2025120909190353520_j_pp-2016-0006_ref_169_w2aab3b7c23b1b6b1ab2b1d169Aa","doi-asserted-by":"crossref","unstructured":"169. Wu JS, Jones DB, Guo LW, Brasfield EB, Ruiz MB, Connett JM, et\u2009al. Effects of pneumoperitoneum on tumor implantation with decreasing tumor inoculum. Dis Colon Rectum 1998;41(2):141\u20136.","DOI":"10.1007\/BF02238239"},{"key":"2025120909190353520_j_pp-2016-0006_ref_170_w2aab3b7c23b1b6b1ab2b1d170Aa","doi-asserted-by":"crossref","unstructured":"170. Wu JS, Brasfield EB, Guo LW, Ruiz M, Connett JM, Philpott GW, et\u2009al. Implantation of colon cancer at trocar sites is increased by low pressure pneumoperitoneum. Surgery 1997;122(1):1\u20137.","DOI":"10.1016\/S0039-6060(97)90256-7"}],"container-title":["Pleura and Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/pp\/1\/1\/article-p23.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2016-0006\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2016-0006\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T09:48:27Z","timestamp":1765273707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2016-0006\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,1]]},"references-count":170,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,4,12]]},"published-print":{"date-parts":[[2016,3,1]]}},"alternative-id":["10.1515\/pp-2016-0006"],"URL":"https:\/\/doi.org\/10.1515\/pp-2016-0006","relation":{},"ISSN":["2364-768X","2364-7671"],"issn-type":[{"value":"2364-768X","type":"electronic"},{"value":"2364-7671","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3,1]]}}}